---
$id: https://graph.org.ai/products/commodity/51202202
$type: Product
source: UNSPSC
code: "51202202"
title: "Laquinimod"
class: "51202200"
classTitle: "Immunosupressant amides"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Laquinimod

**UNSPSC Code**: 51202202
**Class**: [Immunosupressant amides](Immunosupressant amides.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunosuppressant, a biological preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 908SY76S4G, chemically known as 5-chloro-n-ethyl-4-hydroxy-1-methyl-2-oxo-n-phenyl-1,2-dihydroquinoline-3-carboxamide but more generally known as laquinimod, which bears US NIH Compound Identifier 54677946. European Medicines Agency schedules umirolimus in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25236. Most nations, for tariff and trade purposes, schedule LAQUINIMOD under HS 29337900 amd SITC 51561. SMILES: CCN(C1=CC=CC=C1)C(=O)C2=C(C3=C(C=CC=C3Cl)N(C2=O)C)O.

